Advertisement

Topics

Immune Checkpoint Therapeutics Hot Targets Pipeline Analysis [Report Updated: 26042016] Prices from USD $4500

12:56 EDT 18 Aug 2017 | BioPortfolio Report Blog

IMMUNE CHECKPOINT THERAPEUTICS HOT TARGETS PIPELINE ANALYSIS gives comprehensive insights on the various Immune Checkpoint modulators being developed for the treatment of various diseases. The report covers all the drugs being developed in various phases Discovery, Preclinical Clinical development. The pipeline focuses on novel medicines covering small molecules, monoclonal antibodies, Recombinant proteins, Bispecific Ab's, Antibody drug conjugates, Cell therapy, Peptides, Oncolytic viruses and Vaccines. The report also covers hot targets in research for Checkpoint modulators.
This report enables Pharmaceutical /Biotech companies, Academic institutes, Individual researchers, Investors, Medical technology companies, Service providers and other associated stake holders to identify and analyze the available licensing/collaborative commercial opportunities in the Immune Checkpoints Drug market. The report also provides strategic insights on medicines that are likely to have an impact on future Immune Checkpoint treatment space. The report in addition to the monotherapy covers the pipeline for combination therapies associated only with checkpoint agents.
In order to effectively deal various diseases, the immune system needs to be able to generate an appropriate counter response. However, as a part of the natural failsafe mechanism, to limit overactive immune responses that could lead to an autoimmune disease, there are a number of markers immune checkpoint receptors found on both tumor cells and antigen presenting cells dendritic cells, macrophages etc. that can downregulate or suppress T cells once the corresponding ligand is bound. Currently, Researchers are challenged to identify various avenues to prevent T cells from binding these toleranceinducing ligands either through antibodies or recombinant forms of ligand or receptors. So, these T cells remain active and ready to tackle various diseases. Owing to its high response rate and prolonged overall patient survival the checkpoint therapeutics are gaining in popularity and have shown some impressive results in the areas of Oncology, Inflammation, Respiratory, Autoimmune and Infectious disease.

Original Article: Immune Checkpoint Therapeutics Hot Targets Pipeline Analysis [Report Updated: 26042016] Prices from USD $4500

NEXT ARTICLE

More From BioPortfolio on "Immune Checkpoint Therapeutics Hot Targets Pipeline Analysis [Report Updated: 26042016] Prices from USD $4500"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Recombinant DNA
Recombinant DNA is the formation of a novel DNA sequence by the formation of two DNA strands. These are taken from two different organisms. These recombinant DNA molecules can be made with recombinant DNA technology. The procedure is to cut the DNA of ...